Daniel M. Schmitt - 01 Apr 2026 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Reporting relationship: President, CEO and Director, Director
Issuer ticker: ACTU
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Apr 2026, 17:19:52 UTC
Prior SEC filing: 13 Feb 2026
Next SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Paul Lytle, Attorney-in-Fact

Key filing fact

Daniel M. Schmitt filed Form 4 for ACTUATE THERAPEUTICS, INC. (ACTU) on 01 Apr 2026.

Key facts

This page summarizes Daniel M. Schmitt's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2026, 17:19.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001318470 Primary reporting owner

SCHMITT DANIEL M

Relationship: President, CEO and Director, Director
Address: C/O ACTUATE THERAPEUTICS, INC., 1751 RIVER RUN, SUITE 400, FORT WORTH
Signature: /s/ Paul Lytle, Attorney-in-Fact
Signature date: 01 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACTU transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +237,000
Change %
Price: $0.000000^*
Shares after: 237,000
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 237,000
Exercise price: $2.49
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options will vest as to 25% on April 1, 2027 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date.